Medikanuclear S.A. Company Profile - Ecuador | Financials & Key Executives

Medikanuclear S.A. (Ecuador)

Main Activities: Retail Trade

Secondary Activities: Pharmaceutical and Medicine Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Health and Personal Care Stores | Pharmacies and Drug Stores

Full name: Medikanuclear S.A.

Profile Updated: May 14, 2024

Medikanuclear S.A. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Retail Trade industry. The enterprise was incorporated on May 17, 2021. Medikanuclear S.A. currently employs 10 (2023) people. In 2023, the company reported a net sales revenue increase of 320.15%. Its’ total assets recorded a growth of 52.79%. The enterprise’s net profit margin decreased by 0.71% in 2023.

Headquarters
las Casas 650
Quito; Pichincha;

Contact Details: Purchase the Medikanuclear S.A. report to view the information.

Basic Information

Total Employees:

Purchase the Medikanuclear S.A. report to view the information.

Outstanding Shares:

Purchase the Medikanuclear S.A. report to view the information.

Registered Capital:

Purchase the Medikanuclear S.A. report to view the information.

Incorporation Date:

May 17, 2021

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Medikanuclear S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

320.15%▲

Total operating revenue

320.15%▲

Operating profit (EBIT)

25.19%▲

EBITDA

31.27%▲

Net Profit (Loss) for the Period

33.75%▲

Total assets

52.79%▲

Total equity

1.87%▲

Operating Profit Margin (ROS)

-0.79%▼

Net Profit Margin

-0.71%▼

Return on Equity (ROE)

1.74%▲

Quick Ratio

-0.77%▼

Cash Ratio

-0.01%▼

Similar companies

Related EMIS Industry Reports